2018
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma
Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN, Gaffney SG, Townsend JP, Yu JB. CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma. Frontiers In Oncology 2018, 8: 95. PMID: 29670856, PMCID: PMC5893829, DOI: 10.3389/fonc.2018.00095.Peer-Reviewed Original ResearchDisease-free survivalNeck squamous cell carcinomaSquamous cell carcinomaOverall survivalHPV-negative HNSCCPrognostic factorsCell carcinomaPoor survivalLoss groupCDKN2A mRNAMedian disease-free survivalP16 expressionCopy number lossNumber lossMedian overall survivalReceipt of chemotherapyIndependent prognostic factorUseful prognostic factorHPV-negative headHigh p16 expressionProtein expression levelsHPV infectionCancer Genome AtlasBetter prognosisMultivariable analysis
2012
Reevaluation of Epidemiological Data Demonstrates That It Is Consistent With Cross-Immunity Among Human Papillomavirus Types
Durham DP, Poolman EM, Ibuka Y, Townsend JP, Galvani AP. Reevaluation of Epidemiological Data Demonstrates That It Is Consistent With Cross-Immunity Among Human Papillomavirus Types. The Journal Of Infectious Diseases 2012, 206: 1291-1298. PMID: 22872732, PMCID: PMC3448971, DOI: 10.1093/infdis/jis494.Peer-Reviewed Original ResearchConceptsHuman papillomavirus typesEpidemiological dataHPV typesOdds ratioPapillomavirus typesType replacementSpecific HPV typesHPV types 16Future vaccine studiesHPV vaccinationHPV infectionVaccine studiesEpidemiological observationsType 16Single infectionType 18Multiple infectionsType 6Cross immunityVaccinationInfectionPrevalenceEpidemiological modelEpidemiological dynamicsHPV